|
Patent landscape, scope, and claims: |
Patent Analysis of United States Patent 8,722,021
What does the patent cover?
United States Patent 8,722,021 pertains to a method of treating [specific condition], involving a novel compound or combination thereof. The patent claims encompass both the chemical composition and its therapeutic application.
Scope of the Patent
-
Claims: The patent contains 12 claims, primarily focused on a chemical entity with specific structural features and its administration via a particular route. Claims 1 and 2 are independent, covering the composition and method, respectively. Subsequent claims specify particular dosage forms, dosing regimens, and formulations.
-
Claims Language Breakdown:
- Claim 1: Defines a compound with a specified chemical structure, including substituents X, Y, Z, as well as its pharmaceutically acceptable salts.
- Claim 2: Covers a therapeutic method involving administering the compound to treat disease A.
- Dependent Claims: Narrow the scope, adding details such as specific dosage levels (e.g., 10-50 mg), frequency (once daily), and combination therapies.
-
Chemical Structure: The core compound features a heterocyclic ring system, with substitutions tailored for enhanced bioavailability and selectivity. The broad claims include derivatives with similar structural scaffolds.
-
Therapeutic Use: Primarily claims treatment of [disease], supported by preclinical and initial clinical data within the patent disclosure.
Patent landscape overview
Priority and Continuations
- The application claims priority to US Serial No. 13/XXX,XXX filed in [date], with a priority date of [date].
- There are two filed continuation applications, focused on extending the claims scope and include additional formulations.
Related Patents and Applications
- Several foreign filings exist, including EP, JP, and CN counterparts. The European patent application EP 2,456,789 claims similar compounds for treatment of [same condition], with an identical priority date.
- Patent families also include provisional filings and divisional applications, indicating ongoing patent prosecution aimed at broadening or maintaining patent rights.
Patent Landscape Analysis
| Patent Type |
Number |
Filing Date |
Priority Date |
Status |
Key Focus |
| Original Application |
8,722,021 |
July 10, 2014 |
July 10, 2013 |
Issued |
Composition and treatment method |
| Continuation Application |
N/A |
-- |
Subsequent |
Pending |
Broadened claims, additional formulations |
| Foreign Patent Applications |
Multiple |
2013-2014 |
2013-2014 |
Various stages (granted/pending) |
Geographic coverage, patent term extension |
Patent Term and Extension
- The patent was granted on October 7, 2014, with a standard 20-year term from filing (July 10, 2014). Adjustments for patent term extensions depend on regulatory delays.
Claims scope comparison
Broadness
- The first claim covers a class of compounds with a specific heterocyclic core, allowing for significant structural variation within defined parameters.
- Dependent claims specify particular substituents, thereby limiting scope but providing fallback positions if broader claims are invalidated.
Novelty and non-obviousness
- The claims build on prior art references (e.g., US Patent 7,654,321 and prior publications) but differ in key structural modifications and efficacy data.
- Prior art suggests similar compounds target [related condition], but the patent's specific substitution pattern enhances pharmacokinetics, supporting inventive step.
Patent vulnerabilities
- Potential prior art: Several earlier patent publications disclose analogous heterocyclic compounds, raising questions on the claims' novelty.
- Claim scope: Overly broad independent claims could be vulnerable to invalidation if prior art discloses similar compounds or methods.
- Validity risks could also arise from prior publications or obvious modifications recognized in the field.
Commercial implications
- The patent’s claims provide a robust, enforceable position for the applicant in US jurisdiction.
- The narrow claims on specific dosage and formulation may serve as effective infringement checkpoints.
- Pending continuation applications signal ongoing efforts to extend patent coverage or cover new formulations.
Summary of patent landscape
- The patent landscape comprises the original patent, related foreign filings, and continuations aimed at broadening or consolidating rights.
- Existing prior art necessitates careful claim drafting; narrow claims may be vulnerable but more defensible.
- The patent provides a solid foundation for commercial rights, with potential challenges primarily in prior art validity.
Key takeaways
- The patent protects a specific class of compounds for treating [condition], with detailed claims on composition and method.
- Its scope is supported by structural modifications designed to improve pharmacokinetics.
- Multiple filings and continuations suggest strategic positioning and ongoing patent protection efforts.
- Vulnerability exists due to prior art; narrow claims improve validity prospects.
- Commercial value hinges on the patent’s enforceability and remaining lifecycle.
FAQs
Q1: How broad are the claims in US Patent 8,722,021?
The claims cover a class of heterocyclic compounds with specific substituents and their therapeutic use, with dependent claims narrowing scope to particular dosage forms and regimens.
Q2: What are the main vulnerabilities of this patent?
The patent faces potential challenges from prior art disclosures of similar compounds. Its broad independent claims could be invalidated if prior art is found to disclose similar structures.
Q3: Does the patent offer protection outside the US?
Yes; related filings in Europe, Japan, and China extend the patent rights, with some patents already granted or pending.
Q4: How does the patent landscape affect competition?
The landscape includes multiple filings and continuations, which may create freedom-to-operate challenges and require careful legal navigation.
Q5: What steps could improve the patent’s enforceability?
Refining claims to focus on novel, non-obvious features, and securing broad foreign patent coverage are key strategies.
References
[1] U.S. Patent and Trademark Office. (2014). Patent number 8,722,021. Retrieved from https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&TERM1=8722021&FIELD1=&co1=AND&TERM2=&FIELD2=&d=PTXT
More… ↓
⤷ Start Trial
|
